Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH

by Stephanie J. Crowley, Patrick T. Bruck, Md Aladdin Bhuiyan, Amelia Mitchell-Gears, Michael J. Walsh, Kevin Zhangxu, Lestat R. Ali, Hee-Jin Jeong, Jessica R. Ingram, David M. Knipe, Hidde L. Ploegh, Michael Dougan, Stephanie K. Dougan
Published 2020-02-01